1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to 2018

The nerve repair and regeneration market was worth $4.1 billion in 2012 and is expected to grow at a CAGR of 11.5% in the next five years, primarily due to technological advancements and favorable reimbursement policies. The market is expected to witness a high growth in nerve grafting and neuromodulation segments, as they offer effective solutions for peripheral nerve repair and chronic pain, incontinence, heart failure, headache, depression, and epilepsy. Moreover, there are certain devices in clinical trials for newer applications; for instance, deep brain stimulation for Alzheimer’s and depression, and vagus nerve stimulation for heart failure. Novel therapies (such as stem cell therapy) and emerging markets provide huge growth opportunities. However, the major challenges faced by the industry are donor site morbidity and inadequate nerve regenerationby conduits. The neuromodulation market is expected to reach $7.8 billion by 2018.

The peripheral nerve repair segment includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation segment includes internal stimulation devices such asSpinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS),Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS).

A number of factors such as the rapidly aging population, growing number of peripheral nerve injuries and associated diseases like Alzheimer’s, epilepsy, and Parkinson’s are the major reasons for the growth of this market. According to a recent study, around 87% of peripheral nerve injuries are resulted from trauma; the U.S. accounts for around 40% of the global peripheral nerve repair surgeries. According to the International Neurostimulation Society, about 40 million to 50 million patients worldwide suffer from epilepsy and 1.5 million people suffer from Parkinson’s in the U.S. alone. Moreover,treatment for tinnitus represents one of the emerging applications in this market. According to the American Tinnitus Association, about 50 million people suffer from this disease in the U.S. alone.

Major players in the peripheral nerve repair segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.).

Scope of the Report

The global nerve repair and regeneration market has been segmented based on surgery andproducts.Both of these markets are broken down into segments and sub-segments, providing exhaustive value and volume analysis for the years 2011, 2012, 2013, and forecast to 2018. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World), to provide in-depth information on the global scenario.

Global Nerve Repair and Regeneration Market

Nerve Repair and Regeneration Market, by Surgery

Direct Nerve Repair/Neurorraphy
Perineural repair
Epineural repair
Group Fascicular Repair
Nerve Grafting
Autografts
Allografts
Xenografts
Stem cell therapy
Neurostimulation/Neuromodulation surgery

2. Nerve Repair and Regeneration Market, by Products

Nerve repair, by Biomaterials

Nerve Conduits
Nerve Protectors
Nerve Wraps
Nerve Connectors

Nerve repair, by Neurostimulation/Neuromodulation

Internal Neurostimulation
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Gastric Electrical Stimulation

External Neurostimulation

Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation

3. Global Nerve Repair and Regeneration Market, by Geography

North America
Europe
Asia
ROW (Africa, LATAM, Middle-East, andPacific countries)

Table Of Contents

Nerve Repair and Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend and Forecast to 2018
1 INTRODUCTION 20

1.1 KEY TAKE-AWAYS 20
1.2 REPORT DESCRIPTION 20
1.3 MARKETS COVERED 21
1.4 STAKEHOLDERS 23
1.5 MARKET SCOPE 23
1.6 RESEARCH METHODOLOGY 23
1.6.1 MARKET SIZE ESTIMATION 25
1.6.2 MARKET CRACKDOWN and DATA TRIANGULATION 25
1.6.3 KEY DATA POINTS FROM PRIMARY SOURCES 30
1.6.4 KEY DATA POINTS FROM SECONDARY SOURCES 31
1.6.5 ASSUMPTIONS 32

2 EXECUTIVE SUMMARY 33

3 MARKET OVERVIEW 37

3.1 INTRODUCTION 38
3.2 MARKET SEGMENTATION 39
3.3 MARKET DYNAMICS 40
3.3.1 DRIVERS 41
3.3.1.1 Increasing incidence of peripheral nerve injuries and neurological disorders to propel market growth 41
3.3.1.2 Technological advancements in nerve repair to boost the market 41
3.3.1.3 Favorable reimbursement policies encourage the product usage 42
3.3.1.4 Expanded target applications and new indications are expected to stimulate the growth of neuromodulation devices 42
3.3.2 RESTRAINTS 43
3.3.2.1 Lack of surgeons and patient awareness to hamper the growth 43
3.3.2.2 Lack of trained professionals to pose a negative impact on the market growth 43
3.3.3 OPPORTUNITIES 43
3.3.3.1 Novel Therapies such as use of Stem cells 43
3.3.3.2 Emerging Markets 44
3.3.4 CHALLENGES 44
3.3.4.1 Donor site morbidity 44
3.3.4.2 Inadequate nerve regeneration by conduits 44
3.4 REGULATIONS FOR NERVE REPAIR AND REGENERATION PRODUCTS 45
3.4.1 REGULATIONS FOR HUMANITARIAN USE DEVICES (HUD) 45
3.4.2 REGULATIONS FOR ELECTRICALLY POWERED DEVICES 45
3.5 STRATEGIC BENCHMARKING 46
3.5.1 AGREEMENT OF ALAFAIR BIOSCIENCES WITH UNIVERSITY OF TEXAS 47
3.5.2 ACQUISITION OF SYNOVIS LIFE TECHNOLOGIES, INC. BY BAXTER INTERNATIONAL, INC. 47
3.5.3 ACQUISITION OF INTELECT MEDICAL, INC.
BY BOSTON SCIENTIFIC CORPORATION 47
3.5.4 AGREEMENT OF CYBERONICS, INC. WITH CERBOMED, GMBH 47
3.5.5 NEW PRODUCT LAUNCH BY POLYGANICS 48
3.6 MARKET SHARE ANALYSIS 48
3.6.1 NEUROMODULATION MARKET 48
3.6.1.1 Global 48
3.6.1.2 North America 50
3.6.1.3 Europe 51
3.6.1.4 Asia 52
3.6.2 PERIPHERAL NERVE REPAIR MARKET 53
3.6.2.1 Global 53
3.6.2.2 North America 54
3.6.2.3 Europe 55
3.6.2.4 Asia 56

4 GLOBAL NERVE REPAIR AND REGENERATION MARKET 57

4.1 INTRODUCTION 58
4.2 NERVE REPAIR AND REGENERATION MARKET, BY SURGERY 59
4.2.1 DIRECT NERVE REPAIR/NEURORRHAPHY 61
4.2.1.1 Epineural repair 64
4.2.1.2 Perineural repair 65
4.2.1.3 Group Fascicular Repair 66
4.2.2 NERVE GRAFTING 67
4.2.2.1 Autografts 69
4.2.2.2 Allografts 70
4.2.2.3 Xenografts 71
4.2.3 STEM CELL THERAPY 73
4.2.4 NEUROSTIMULATION/NEUROMODULATION SURGERY 74
4.2.4.1 External Neurostimulation/Neuromodulation surgery 77
4.2.4.2 Internal Neurostimulation/Neuromodulation surgery 78
4.3 NERVE REPAIR AND REGENERATION MARKET,
BY PRODUCTS 79
4.3.1 NERVE REPAIR BY BIOMATERIALS 81
4.3.1.1 Nerve Conduits 83
4.3.1.2 Nerve Protectors 85
4.3.1.3 Nerve Wraps 86
4.3.1.4 Nerve Connectors 87
4.3.2 NERVE REPAIR BY NEUROSTIMULATION/ NEUROMODULATION 88
4.3.2.1 Internal Neurostimulation 93
4.3.2.1.1 Spinal Cord Stimulation 97
4.3.2.1.2 Deep Brain Stimulation 99
4.3.2.1.3 Sacral Nerve Stimulation 101
4.3.2.1.4 Vagus Nerve Stimulation 103
4.3.2.1.5 Gastric Electrical Stimulation 104
4.3.2.2 External Neurostimulation 106
4.3.2.2.1 Transcutaneous Electrical Nerve Stimulation 110
4.3.2.2.2 Transcranial Magnetic Stimulation 112

5 GEOGRAPHIC ANALYSIS 115

5.1 INTRODUCTION 116
5.2 NORTH AMERICA 119
5.3 EUROPE 126
5.4 ASIA 133
5.5 REST OF THE WORLD 140

6 COMPETITIVE LANDSCAPE 148

6.1 INTRODUCTION 149
6.2 MERGERS and ACQUISITIONS 150
6.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS and
JOINT VENTURES 152
6.4 NEW PRODUCT LAUNCH 153
6.5 EXPANSIONS 155
6.6 APPROVALS 156

7 COMPANY PROFILES 158 (Overview, Financials, Products and Services, Strategy, and Developments)*

7.1 ALAFAIR BIOSCIENCES, INC. 158
7.2 AXOGEN, INC. 160
7.3 BAXTER INTERNATIONAL, INC. 165
7.4 BIOCONTROL MEDICAL 171
7.5 BOSTON SCIENTIFIC CORPORATION 174
7.6 CYBERONICS, INC. 183
7.7 INTEGRA LIFESCIENCES HOLDINGS CORP. 188
7.8 MEDTRONIC, INC. 194
7.9 ORTHOMED S.A.S. 202
7.10 POLYGANICS 204
7.11 SALUMEDICA 207
7.12 ST. JUDE MEDICAL 209
7.13 STRYKER CORPORATION 218
*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.

8 APPENDIX 225

LIST OF TABLES

TABLE 1 GLOBAL NERVE REPAIR and REGENERATION MARKET, BY PRODUCTS, 2011 - 2018 ($MILLION) 34
TABLE 2 GLOBAL NERVE REPAIR and REGENERATION SURGERY MARKET,
BY VOLUME, 2011 - 2018 (NO. OF SURGERIES) 35
TABLE 3 GLOBAL NERVE REPAIR and REGENERATION SURGERY MARKET,
BY VOLUME, 2011 - 2018 (NO. OF SURGERIES) 60
TABLE 4 GLOBAL NERVE REPAIR and REGENERATION SURGERY MARKET VOLUME, BY GEOGRAPHY, 2011 - 2018 (NO. OF SURGERIES) 61
TABLE 5 GLOBAL DIRECT NERVE REPAIR and REGENERATION SURGERY MARKET VOLUME, BY TYPE, 2011 - 2018 (NO. OF SURGERIES) 62
TABLE 6 DIRECT NERVE REPAIR and REGENERATION SURGERY MARKET VOLUME, BY GEOGRAPHY, 2011 - 2018 (NO. OF SURGERIES) 63
TABLE 7 EPINEURAL NERVE REPAIR and REGENERATION SURGERY MARKET VOLUME, BY GEOGRAPHY, 2011 - 2018 (NO. OF SURGERIES) 64
TABLE 8 PERINEURAL NERVE REPAIR and REGENERATION SURGERY MARKET VOLUME, BY GEOGRAPHY, 2011 - 2018 (NO. OF SURGERIES) 65
TABLE 9 GROUP FASCICULAR NERVE REPAIR and REGENERATION SURGERY MARKET VOLUME, BY GEOGRAPHY, 2011 - 2018 (NO. OF SURGERIES) 66
TABLE 10 GLOBAL NERVE GRAFTING NERVE REPAIR and REGENERATION SURGERY MARKET VOLUME, BY TYPE, 2011 - 2018 (NO. OF SURGERIES) 68
TABLE 11 NERVE GRAFTING NERVE REPAIR and REGENERATION SURGERY MARKET VOLUME, BY GEOGRAPHY, 2011 - 2018 (NO. OF SURGERIES) 69
TABLE 12 AUTOGRAFTS NERVE REPAIR and REGENERATION SURGERY MARKET VOLUME, BY GEOGRAPHY, 2011 - 2018 (NO. OF SURGERIES) 70
TABLE 13 ALLOGRAFTS NERVE REPAIR and REGENERATION SURGERY MARKET VOLUME, BY GEOGRAPHY, 2011 - 2018 (NO. OF SURGERIES) 71
TABLE 14 XENOGRAFTS NERVE REPAIR and REGENERATION SURGERY MARKET VOLUME, BY GEOGRAPHY, 2011 - 2018 (NO. OF SURGERIES) 72
TABLE 15 STEM CELL THERAPY MARKET VOLUME, BY GEOGRAPHY,
2011 - 2018 (NO. OF SURGERIES) 73
TABLE 16 GLOBAL NEUROSTIMULATION NERVE REPAIR and REGENERATION MARKET VOLUME, BY TYPE, 2011 - 2018 (NO. OF SURGERIES) 75
TABLE 17 NEUROSTIMULATION NERVE REPAIR and REGENERATION SURGERY MARKET VOLUME, BY GEOGRAPHY, 2011 - 2018 (NO. OF SURGERIES) 76
TABLE 18 EXTERNAL NEUROSTIMULATION SURGERY MARKET VOLUME,
BY GEOGRAPHY, 2011 - 2018 (NO. OF SURGERIES) 77
TABLE 19 INTERNAL NEUROSTIMULATION SURGERY MARKET VOLUME,
BY GEOGRAPHY, 2011 - 2018 (NO. OF SURGERIES) 78
TABLE 20 GLOBAL NERVE REPAIR and REGENERATION MARKET, BY PRODUCTS, 2011 - 2018 ($MILLION) 79
TABLE 21 NERVE REPAIR and REGENERATION PRODUCTS MARKET, BY GEOGRAPHY, 2011 - 2018 ($MILLION) 80
TABLE 22 NERVE REPAIR and REGENERATION BIOMATERIALS MARKET,
BY GEOGRAPHY, 2011 - 2018 ($MILLION) 82
TABLE 23 NERVE REPAIR and REGENERATION BIOMATERIALS MARKET,
BY PRODUCTS, 2011 - 2018 ($MILLION) 83
TABLE 24 NERVE CONDUITS MARKET, BY GEOGRAPHY, 2011 - 2018 ($MILLION) 84
TABLE 25 NERVE PROTECTORS MARKET, BY GEOGRAPHY,
2011 - 2018 ($MILLION) 85
TABLE 26 NERVE WRAPS MARKET, BY GEOGRAPHY, 2011 - 2018 ($MILLION) 86
TABLE 27 NERVE CONNECTOR MARKET, BY GEOGRAPHY, 2011 - 2018 ($MILLION) 87
TABLE 28 GLOBAL NEUROSTIMULATION PRODUCTS MARKET, BY TYPE,
2011 - 2018 ($MILLION) 89
TABLE 29 GLOBAL NEUROSTIMULATION PRODUCTS VOLUME MARKET, BY TYPE, 2011 - 2018 (NO. OF UNITS) 91
TABLE 30 NEUROSTIMULATION PRODUCTS MARKET, BY GEOGRAPHY,
2011 - 2018 ($MILLION) 93
TABLE 31 GLOBAL INTERNAL NEUROSTIMULATION MARKET REVENUE, BY TYPE, 2011 - 2018 ($MILLION) 94
TABLE 32 GLOBAL INTERNAL NEUROSTIMULATION MARKET VOLUME, BY TYPE, 2011 - 2018 (NO. OF UNITS) 95
TABLE 33 INTERNAL NEUROSTIMULATION MARKET REVENUE, BY GEOGRAPHY, 2011 - 2018 ($MILLION) 96
TABLE 34 INTERNAL NEUROSTIMULATION MARKET VOLUME, BY GEOGRAPHY, 2011 - 2018 (NO. OF UNITS) 97
TABLE 35 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY,
2011 - 2018 ($MILLION) 98
TABLE 36 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY,
2011 - 2018 ($MILLION) 100
TABLE 37 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY,
2011 - 2018 ($MILLION) 102
TABLE 38 VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY,
2011 - 2018 ($MILLION) 104
TABLE 39 GASTRIC ELECTRICAL STIMULATION MARKET, BY GEOGRAPHY,
2011 - 2018 ($MILLION) 106
TABLE 40 GLOBAL EXTERNAL NEUROSTIMULATION NERVE REPAIR and REGENERATION MARKET, BY TYPE, 2011 - 2018 ($MILLION) 107
TABLE 41 GLOBAL EXTERNAL NEUROSTIMULATION MARKET VOLUME, BY TYPE, 2011 - 2018 (NO. OF UNITS) 108
TABLE 42 EXTERNAL NEUROSTIMULATION MARKET, BY GEOGRAPHY,
2011 - 2018 ($MILLION) 109
TABLE 43 EXTERNAL NEUROSTIMULATION MARKET VOLUME, BY GEOGRAPHY, 2011 - 2018 (NO. OF UNITS) 110
TABLE 44 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET,
BY GEOGRAPHY, 2011 - 2018 ($MILLION) 112
TABLE 45 TRANSCRANIAL MAGNETIC STIMULATION MARKET, BY GEOGRAPHY, 2011- 2018 ($MILLION) 114
TABLE 46 NERVE REPAIR and REGENERATION PRODUCTS MARKET REVENUE,
BY GEOGRAPHY, 2011 - 2018 ($MILLION) 118
TABLE 47 NERVE REPAIR and REGENERATION SURGERY MARKET VOLUME,
BY GEOGRAPHY, 2011 - 2018 (NO. OF SURGERIES) 119
TABLE 48 NORTH AMERICA: NERVE REPAIR and REGENERATION MARKET,
BY PRODUCTS, 2011 - 2018 ($MILLION) 120
TABLE 49 NORTH AMERICA: NERVE REPAIR and REGENERATION SURGERY MARKET, BY VOLUME, 2011 - 2018 (NO. OF SURGERIES) 121
TABLE 50 NORTH AMERICA: DIRECT NERVE REPAIR and REGENERATION SURGERY MARKET, BY VOLUME, 2011 - 2018 (NO. OF SURGERIES) 122
TABLE 51 NORTH AMERICA: NERVE GRAFTINGSURGERY MARKET, BY VOLUME, 2011 - 2018 (NO. OF SURGERIES) 122
TABLE 52 NORTH AMERICA: XENOGRAFTS NERVE REPAIR and REGENERATION MARKET, BY PRODUCTS, 2011 - 2018 ($MILLION) 123
TABLE 53 NORTH AMERICA: NEUROSTIMULATION MARKET, BY PRODUCTS,
2011 - 2018 ($MILLION) 124
TABLE 54 NORTH AMERICA: NEUROSTIMULATION SURGERY MARKET,
BY VOLUME, 2011 - 2018 (NO. OF SURGERIES) 124
TABLE 55 NORTH AMERICA: INTERNAL NEUROSTIMULATION MARKET,
BY PRODUCTS, 2011 - 2018 ($MILLION) 125
TABLE 56 NORTH AMERICA: EXTERNAL NEUROSTIMULATION MARKET,
BY PRODUCTS, 2011 - 2018 ($MILLION) 126
TABLE 57 EUROPE: NERVE REPAIR and REGENERATION MARKET, BY PRODUCTS, 2011 - 2018 ($MILLION) 127
TABLE 58 EUROPE: NERVE REPAIR and REGENERATION SURGERY MARKET,
BY VOLUME, 2011 - 2018 (NO. OF SURGERIES) 128
TABLE 59 EUROPE: DIRECT NERVE REPAIR and REGENERATION SURGERY MARKET, BY VOLUME, 2011 - 2018 (NO. OF SURGERIES) 129
TABLE 60 EUROPE: NERVE GRAFTING SURGERY MARKET, BY VOLUME,
2011 - 2018 (NO. OF SURGERIES) 129
TABLE 61 EUROPE: XENOGRAFTS NERVE REPAIR and REGENERATION MARKET,
BY PRODUCTS, 2011 - 2018 ($MILLION) 130
TABLE 62 EUROPE: NEUROSTIMULATION MARKET, BY PRODUCTS,
2011 - 2018 ($MILLION) 131
TABLE 63 EUROPE: NEUROSTIMULATION SURGERY MARKET, BY VOLUME,
2011 - 2018 (NO. OF SURGERIES) 131
TABLE 64 EUROPE: INTERNAL NEUROSTIMULATION MARKET, BY PRODUCTS, 2011 - 2018 ($MILLION) 132
TABLE 65 EUROPE: EXTERNAL NEUROSTIMULATION MARKET, BY PRODUCTS, 2011 - 2018 ($MILLION) 133
TABLE 66 ASIA: NERVE REPAIR and REGENERATION MARKET, BY PRODUCTS,
2011 - 2018 ($MILLION) 134
TABLE 67 ASIA: NERVE REPAIR and REGENERATION SURGERY MARKET,
BY VOLUME, 2011 - 2018 (NO. OF SURGERIES) 135
TABLE 68 ASIA: DIRECT NERVE REPAIR and REGENERATION SURGERY MARKET,
BY VOLUME, 2011 - 2018 (NO. OF SURGERIES) 136
TABLE 69 ASIA: NERVE GRAFTING SURGERY MARKET, BY VOLUME,
2011 - 2018 (NO. OF SURGERIES) 136
TABLE 70 ASIA: XENOGRAFTS NERVE REPAIR and REGENERATION MARKET,
BY PRODUCTS, 2011 - 2018 ($MILLION) 137
TABLE 71 ASIA: NEUROSTIMULATION MARKET, BY PRODUCTS,
2011 - 2018 ($MILLION) 138
TABLE 72 ASIA: NEUROSTIMULATION SURGERY MARKET, BY VOLUME,
2011 - 2018 (NO. OF SURGERIES) 138
TABLE 73 ASIA: INTERNAL NEUROSTIMULATION MARKET, BY PRODUCTS,
2011 - 2018 ($MILLION) 139
TABLE 74 ASIA: EXTERNAL NEUROSTIMULATION MARKET, BY PRODUCTS,
2011 - 2018 ($MILLION) 140
TABLE 75 ROW: NERVE REPAIR and REGENERATION MARKET, BY PRODUCTS,
2011 - 2018 ($MILLION) 141
TABLE 76 ROW: NERVE REPAIR and REGENERATION SURGERY MARKET,
BY VOLUME, 2011 - 2018 (NO. OF SURGERIES) 142
TABLE 77 ROW: DIRECT NERVE REPAIR and REGENERATION SURGERY MARKET,
BY VOLUME, 2011 - 2018 (NO. OF SURGERIES) 143
TABLE 78 ROW: NERVE GRAFTING SURGERY MARKET, BY VOLUME,
2011 - 2018 (NO. OF SURGERIES) 143
TABLE 79 ROW: XENOGRAFTS NERVE REPAIR and REGENERATION MARKET,
BY PRODUCTS, 2011 - 2018 ($MILLION) 144
TABLE 80 ROW: NEUROSTIMULATION MARKET, BY PRODUCTS,
2011 - 2018 ($MILLION) 145
TABLE 81 ROW: NEUROSTIMULATION SURGERY MARKET, BY VOLUME,
2011 - 2018 (NO. OF SURGERIES) 145
TABLE 82 ROW: INTERNAL NEUROSTIMULATION MARKET, BY PRODUCTS,
2011 - 2018 ($MILLION) 146
TABLE 83 ROW: EXTERNAL NEUROSTIMULATION MARKET,BY PRODUCTS,
2011 - 2018 ($MILLION) 147
TABLE 84 MERGERS and ACQUISITIONS (JANUARY 2011 - MARCH 2013) 151
TABLE 85 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, CONTRACTS,
and JOINT VENTURES (APRIL 2011 - SEPTEMBER 2012) 152
TABLE 86 NEW PRODUCT LAUNCHES (MAY 2011 - SEPTEMBER 2012) 154
TABLE 87 EXPANSIONS (MAY 2012 - JULY 2012) 155
TABLE 88 APPROVALS (JANUARY 2011 - JUNE 2013) 156

LIST OF FIGURES

FIGURE 1 MARKET CRACKDOWN and DATA TRIANGULATION METHODOLOGY FOR PERIPHERAL NERVE REPAIR PRODUCTS MARKET 26
FIGURE 2 MARKET CRACKDOWN and DATA TRIANGULATION METHODOLOGY FOR PERIPHERAL NERVE REPAIR SURGERY MARKET 27
FIGURE 3 MARKET CRACKDOWN and DATA TRIANGULATION METHODOLOGY FOR
NEUROMODULATION MARKET 28
FIGURE 4 MARKET FORECASTING MODEL 29
FIGURE 5 RESEARCH OUTPUT - 360O VALIDATION 30
FIGURE 6 NERVE REPAIR and REGENERATION MARKET, BY GEOGRAPHY,
2011 - 2018 ($MILLION) 36
FIGURE 7 NERVE REPAIR AND REGENERATION MARKET SEGMENTATION 39
FIGURE 8 MARKET DYNAMICS 40
FIGURE 9 STRATEGIC BENCHMARKING: PRODUCT EXPANSION and ENHANCEMENT 46
FIGURE 10 GLOBAL NEUROMODULATION PRODUCTS: MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2012 49
FIGURE 11 NORTH AMERICA: NEUROMODULATION PRODUCTS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2012 50
FIGURE 12 EUROPE: NEUROMODULATION PRODUCTS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2012 51
FIGURE 13 ASIA: NEUROMODULATION PRODUCTS MARKET SHARE ANALYSIS,
BY KEY PLAYERS, 2012 52
FIGURE 14 GLOBAL PERIPHERAL NERVE REPAIR and REGENERATION PRODUCTS: MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2012 53
FIGURE 15 NORTH AMERICA: PERIPHERAL NERVE REPAIR and REGENERATION PRODUCTS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2012 54
FIGURE 16 EUROPE: PERIPHERAL NERVE REPAIR and REGENERATION PRODUCTS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2012 55
FIGURE 17 ASIA: PERIPHERAL NERVE REPAIR and REGENERATION PRODUCTS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2012 56
FIGURE 18 NUMBER OF PERIPHERAL NERVE REPAIR SURGERIES, BY TYPE,
2011 - 2018 (THOUSANDS) 59
FIGURE 19 DIRECT NERVE REPAIR SURGERIES, BY TYPE, 2013 62
FIGURE 20 NERVE GRAFTING SURGERIES, BY TYPE, 2013 67
FIGURE 21 NUMBER OF NEUROMODULATION SURGERIES, 2013 (THOUSANDS) 74
FIGURE 22 NEUROMODULATION MARKET, VALUE - VOLUME COMPARISON,
BY TYPE, 2013 88
FIGURE 23 LIFECYCLE OF NEUROMODULATION PRODUCTS 90
FIGURE 24 OPPORTUNITY MATRIX: NEUROMODULATION PRODUCTS, 2013 92
FIGURE 25 NERVE REPAIR BIOMATERIALS MARKET GEOGRAPHIC and PRODUCT ANALYSIS, 2013 ($MILLION) 117
FIGURE 26 GLOBAL NERVE REPAIR AND REGENERATION MARKET,
BY GEOGRAPHY, 2013 118
FIGURE 27 GEOGRAPHIC REACH VS PRODUCT PORTFOLIO ANALYSIS:
KEY PLAYERS 148
FIGURE 28 KEY GROWTH STRATEGIES IN NERVE REPAIR and REGENERATION MARKET, 2011 - 2013 149
FIGURE 29 AXOGEN, INC.: TOTAL REVENUE AND RandD EXPENSES,
2009 - 2012 ($MILLION) 161
FIGURE 30 AXOGEN: SWOT ANALYSIS 164
FIGURE 31 BAXTER INTERNATIONAL, INC.: TOTAL REVENUE AND RandD EXPENSES, 2009 - 2012 ($BILLION) 166
FIGURE 32 BAXTER INTERNATIONAL, INC.: GEOGRAPHIC REVENUE MIX, 2012 167
FIGURE 33 BAXTER INTERNATIONAL, INC.:BUSINESS REVENUE MIX, 2012 168
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND RandD EXPENSES, 2009 - 2012 ($BILLION) 175
FIGURE 35 BOSTON SCIENTIFIC CORPORATION: GEOGRAPHIC REVENUE MIX, 2012 176
FIGURE 36 BOSTON SCIENTIFIC CORPORATION: BUSINESS REVENUE MIX, 2012 177
FIGURE 37 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS 181
FIGURE 38 CYBERONICS, INC.: TOTAL REVENUE AND RandD EXPENSES,
2010 - 2013 ($MILLION) 184
FIGURE 39 CYBERONICS, INC.: GEOGRAPHIC REVENUE MIX, 2013 185
FIGURE 40 INTEGRA LIFESCIENCES HOLDING CORP.: TOTAL REVENUE AND RandD EXPENSES, 2009 - 2012 ($MILLION) 189
FIGURE 41 INTEGRA LIFESCIENCES HOLDING CORP.: GEOGRAPHIC REVENUE MIX, 2012 190
FIGURE 42 INTEGRA LIFESCIENCES HOLDING CORP.: BUSINESS REVENUE MIX, 2012 191
FIGURE 43 MEDTRONIC, INC.: TOTAL REVENUE AND RandD EXPENSES,
2009 - 2012 ($BILLION) 195
FIGURE 44 MEDTRONIC, INC.: GEOGRAPHIC REVENUE MIX, 2012 196
FIGURE 45 MEDTRONIC, INC.:BUSINESS REVENUE MIX, 2012 197
FIGURE 46 MEDTRONIC: SWOT ANALYSIS 200
FIGURE 47 ST. JUDE MEDICAL, INC.: TOTAL REVENUE AND RandD EXPENSES,
2009 - 2012 ($BILLION) 210
FIGURE 48 ST. JUDE MEDICAL, INC.: GEOGRAPHIC REVENUE MIX, 2012 211
FIGURE 49 ST. JUDE MEDICAL, INC.: BUSINESS REVENUE MIX, 2012 212
FIGURE 50 ST JUDE MEDICAL: SWOT ANALYSIS 216
FIGURE 51 STRYKER CORPORATION: TOTAL REVENUE AND RandD EXPENSES,
2009 - 2012 ($BILLION) 219
FIGURE 52 STRYKER CORPORATION: GEOGRAPHIC REVENUE MIX, 2012 220
FIGURE 53 STRYKER CORPORATION: BUSINESS REVENUE MIX, 2012 221
FIGURE 54 STRYKER CORPORATION: SWOT ANALYSIS 223

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Adhesion Barrier Market by Product, Product Form, Application - Global Forecast to 2021

Adhesion Barrier Market by Product, Product Form, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global adhesion barriers market is expected to grow at a CAGR of 8.4% during the forecast period of 2016 to 2021. This market is projected to reach USD 1,216.8 million by 2021 from USD 812.5 million ...

Laparoscopic Instruments Market by Product, Application, End User - Analysis & Global Forecast to 2021

Laparoscopic Instruments Market by Product, Application, End User - Analysis & Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global laparoscopic instruments market is expected to reach USD 11.68 billion by 2021 from USD 7.61 billion in 2016, growing at a CAGR of 8.9%. Over the years, factors such as growing patient and physician ...

Czech Republic Cardiovascular Surgery Devices Market Outlook to 2022

Czech Republic Cardiovascular Surgery Devices Market Outlook to 2022

  • $ 4995
  • Industry report
  • September 2016
  • by Global Data

Czech Republic Cardiovascular Surgery Devices Market Outlook to 2022 Summary GlobalData’s new report, Czech Republic Cardiovascular Surgery Devices Market Outlook to 2022, provides key market data on ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.